![Balancing act: Weighing up the benefits versus adverse effects of antidepressants | New Zealand Doctor Balancing act: Weighing up the benefits versus adverse effects of antidepressants | New Zealand Doctor](https://www.nzdoctor.co.nz/sites/default/files/styles/free_crop_body_with_image/public/2021-07/6DEDlOE-1lVx21Sc_0GceSa7Al6Hq9yze.jpg?h=72007eba&itok=rDMO7Ihx)
Balancing act: Weighing up the benefits versus adverse effects of antidepressants | New Zealand Doctor
![The first 100 patients in the SUN(^_^)D trial (strategic use of new generation antidepressants for depression): examination of feasibility and adherence during the pilot phase | Trials | Full Text The first 100 patients in the SUN(^_^)D trial (strategic use of new generation antidepressants for depression): examination of feasibility and adherence during the pilot phase | Trials | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1745-6215-13-80/MediaObjects/13063_2011_Article_1008_Fig1_HTML.jpg)
The first 100 patients in the SUN(^_^)D trial (strategic use of new generation antidepressants for depression): examination of feasibility and adherence during the pilot phase | Trials | Full Text
![Antidepressant Switching After the First Failed Trial in Major Depressive Disorder (Node 4B - Part 1) - Psychopharmacology Institute Antidepressant Switching After the First Failed Trial in Major Depressive Disorder (Node 4B - Part 1) - Psychopharmacology Institute](https://cdn.psychopharmacologyinstitute.com/transcripts/%5B2409%5D%20Antidepressant%20Switching%20After%20the%20First%20Failed%20Trial%20in%20Major%20Depressive%20Disorder/image4-1.jpeg)
Antidepressant Switching After the First Failed Trial in Major Depressive Disorder (Node 4B - Part 1) - Psychopharmacology Institute
![Combining antidepressants: a review of evidence | Advances in Psychiatric Treatment | Cambridge Core Combining antidepressants: a review of evidence | Advances in Psychiatric Treatment | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20180507083629670-0483:S1355514600005460:S1355514600005460_tab1.gif?pub-status=live)
Combining antidepressants: a review of evidence | Advances in Psychiatric Treatment | Cambridge Core
![Navigating the Sequenced Treatment Alternatives to Relieve Depression (STAR∗D) Study: Practical Outcomes and Implications for Depression Treatment in Primary Care - ScienceDirect Navigating the Sequenced Treatment Alternatives to Relieve Depression (STAR∗D) Study: Practical Outcomes and Implications for Depression Treatment in Primary Care - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0095454307000401-gr1.jpg)
Navigating the Sequenced Treatment Alternatives to Relieve Depression (STAR∗D) Study: Practical Outcomes and Implications for Depression Treatment in Primary Care - ScienceDirect
![PDF] Trazodone Addition to Paroxetine and Mirtazapine in a Patient with Treatment-Resistant Depression: The Pros and Cons of Combining Three Antidepressants | Semantic Scholar PDF] Trazodone Addition to Paroxetine and Mirtazapine in a Patient with Treatment-Resistant Depression: The Pros and Cons of Combining Three Antidepressants | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/908ba02e3563c2ac949f964a86ad92f4280031dc/4-Table1-1.png)
PDF] Trazodone Addition to Paroxetine and Mirtazapine in a Patient with Treatment-Resistant Depression: The Pros and Cons of Combining Three Antidepressants | Semantic Scholar
![Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis | Molecular Psychiatry Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis | Molecular Psychiatry](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41380-022-01824-z/MediaObjects/41380_2022_1824_Fig1_HTML.png)
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis | Molecular Psychiatry
![A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-019-3390-8/MediaObjects/13063_2019_3390_Fig1_HTML.png)